Journal Guide

Clinical Microbiology and Infection (CMI) is a monthly publication in English of the European Society of Clinical Microbiology and Infectious Diseases and publishes peer-reviewed papers that present basic and applied research relevant to therapy and diagnostics in the fields of microbiology, infectious diseases, virology, parasitology, immunology and epidemiology.

Based on the concept of "One World, One Health, One Medicine", interdisciplinary cooperation between specialists in human and animal medicine is of mutual interest and benefit. Therefore, there is need to combine the respective interest of physicians, veterinarians and other health professionals for comparative studies relevant to either human or animal medicine.Comparative Immunology, Microbiology & Infectious Diseases aims to respond to this concept of "One World, One Health, One Medicine" and to provide a venue for scientific exchange.The journal is open to subjects of common interest related to the immunology, immunopathology, microbiology and epidemiology of human and animal infectious diseases, especially zoonotic infections, and animal models of human infectious diseases. The role of environmental factors in disease emergence is emphasized.Original research papers of high quality and novelty on aspects of host response, molecular biology, pathogenesis, control and prevention and treatment of microbial diseases of domestic animals and wildlife (if the infections are of zoonotic interest and/or in relation with domestic animals), laboratory animals and animal models of human infections are considered for publication. Papers dealing primarily with epidemiology will only be considered if they demonstrate a clear impact on the pathogenesis or prevention of a disease. Similarly, articles addressing microbiology, immunology or pathogenesis must address issues of comparative medical interest.Review articles are highly appreciated. They should focus either on a pathogen or on analyses of the mechanisms of host-microbe interactions including epidemiological studies.Papers focusing solely on diagnostic techniques, case reports or drug trials will not be published. Papers of geographically limited interest, which repeat what had been established elsewhere, will not be considered. The readership of the journal is global. The Editors reserve the right to suggest submission to another journal for those papers which they feel would be more appropriate for consideration by that journal.Papers will be rejected if standards of care of, or procedures performed on animals are not beyond those expected of humane veterinary care. Standards must, at least, meet the International Guiding Principles for Biomedical Research involving Animals, as issued by the Council for International Organizations of Medical Sciences. (C.I.O.M.S., c/o WHO, CH 1211 Geneva 27, Switzerland).

This journal intends to provide clear, insightful, balanced contributions that review the most important, recently published clinical findings related to the diagnosis, treatment, management, and prevention of fungal infections.

We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as advances in diagnosis, current and emerging management approaches, and genomics and pathogenesis. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. Commentaries from well-known figures in the field are also provided, and an international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research.

Current HIV Research covers all the latest and outstanding developments of HIV research by publishing original research, review articles and guest edited thematic issues. The novel pioneering work in the basic and clinical fields on all areas of HIV research covers: virus replication and gene expression, HIV assembly, virus-cell interaction, viral pathogenesis, epidemiology and transmission, anti-retroviral therapy and adherence, drug discovery, the latest developments in HIV/AIDS vaccines and animal models, mechanisms and interactions with AIDS related diseases, social and public health issues related to HIV disease, and prevention of viral infection. Periodically, the journal invites guest editors to devote an issue on a particular area of HIV research of great interest that increases our understanding of the virus and its complex interaction with the host.

This journal intends to provide clear, insightful, balanced contributions by international experts that review the most important, recently published clinical findings related to the diagnosis, treatment, management, and prevention of HIV/AIDS.

We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as antiretroviral therapies, behavioral aspects of management, and metabolic complications and comorbidity. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.

This journal intends to provide clear, insightful, balanced contributions by international experts that review the most important, recently published clinical findings related to the diagnosis, treatment, management, and prevention of infectious disease.

We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as HIV/AIDS, sexually transmitted diseases, tropical and travel medicine, and urinary tract infections. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.

Current Opinion in HIV and AIDS offers full and complete coverage enabling clinicians and researchers to keep up-to-date with the vast amount of information published in the field. Insightful editorials and on-the-mark invited reviews bring readers up-to-speed on key subjects such as the T-cell in HIV infection and disease, reservoirs, host factors, HIV vaccines, antiretroviral therapy and clinical trial design.Website: www.co-hivandaids.com.

With its easy-to-digest reviews on important advances in world literature, Current Opinion in Infectious Diseases offers expert evaluation on a wide range of topics from eleven key disciplines, including HIV infections and AIDS, skin and soft tissue infections, and respiratory infections. Published bimonthly, each issue covers in detail the most pertinent advances in these fields from the previous year. Every issue also contains an in-depth bibliography gleaned from several hundred top journals in the field, complete with annotations detailing the merits of the most important papers.

Current Opinion in Microbiology is a systematic review journal that aims to provide specialists with a unique and educational platform to keep up-to-date with the expanding volume of information published in the field of microbiology. It consists of 6 issues per year covering the following 11 sections, each of which is reviewed once a year:Host-microbe interactions: bacteriaCell regulationEcology and industrial microbiologyHost-microbe interactions: fungi/parasites/virusesAntimicrobialsGenomicsGrowth and development: eukaryotes/prokaryotesThere is also a section that changes every year to reflect hot topics in the field.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Diagnostic Microbiology and Infectious Disease keeps you informed of the latest developments in clinical microbiology and the diagnosis and treatment of infectious diseases. Packed with rigorously peer-reviewed articles and studies in bacteriology, immunology, immunoserology, infectious diseases, mycology, parasitology, and virology. The journal examines new procedures, unusual cases, controversial issues, and important new literature.Diagnostic Microbiology and Infectious Disease's distinguished independent editorial board, consisting of experts from many medical specialties, ensures you extensive and authoritative coverage.Diagnostic Microbiology and Infectious Disease features:– Informed commentaries on new antibiotics– Rapid and cost-effective methods in the laboratory– Instructive case studies with emphasis on complex circumstances– Insightful editorials on important current issues– Book reviews that keep you up-to-date on recently published literature.Diagnostic Microbiology and Infectious Disease also covers such areas as laboratory and clinical management of microbial diseases, epidemiology and pathogenesis of infections, automation in the diagnostic microbiology laboratory, and antibiotic susceptibility testing.

Drug Resistance Updates is a bimonthly publication that contains thought-provoking reviews on important developments in drug resistance in infectious disease and cancer as well as novel drugs and strategies to overcome drug resistance.It covers both basic research and clinical aspects of drug resistance, and involves disciplines as diverse as molecular biology, biochemistry, cell biology, pharmacology, microbiology, preclinical therapeutics, oncology and clinical medicine.Articles are written by leaders in the field, in response to an invitation from the Editors, and are peer-reviewed prior to publication. Articles are clear, readable, and up-to-date, suitable for a multidisciplinary readership and include schematic diagrams and other illustrations conveying the major points of the article. The goal is to highlight recent areas of growth and put them in perspective.*Expert reviews in clinical and basic drug resistance research in oncology and infectious disease *Describes emerging technologies and therapies, particularly those that overcome drug resistance *Emphasises common themes in microbial and cancer research

Welcome to the Centers for Disease Control and Prevention. For over 60 years, CDC has been dedicated to protecting health and promoting quality of life through the prevention and control of disease, injury, and disability. We are committed to programs that reduce the health and economic consequences of the leading causes of death and disability, thereby ensuring a long, productive, healthy life for all people.

Emerging Microbes & Infections (EMI) is a new open access, fully peer-reviewed international journal. The purpose of EMI is to provide a forum to publish a wide range of scientific reports related to emerging infectious diseases, especially with new information from developing countries where such diseases are constantly arising and being discovered regularly. It will report discoveries of emerging microbes (bacteria, viruses, fungi and other pathogens) including their previously unknown phenotypic or genotypic characteristics, as well as cutting edge information associated with microbial mechanisms of pathogenesis, immune evasion and protection, clinical presentation and outcome, drug efficacy and its resistance, epidemiology and other issues important to global health.

Epidemics publishes papers on infectious disease dynamics in the broadest sense. Its scope covers both within-host dynamics of infectious agents and dynamics at the population level, particularly the interaction between the two. Areas of emphasis include: spread, transmission, persistence, implications and population dynamics of infectious diseases; population and public health as well as policy aspects of control and prevention; dynamics at the individual level; interaction with the environment, ecology and evolution of infectious diseases, as well as population genetics of infectious agents.The journal will only publish papers that use high quality novel or published data in their analysis. Successful manuscripts are typically multidisciplinary and integrative. Methodological manuscripts are only acceptable if they present a clear and relevant biological application for which novel insight is gained.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Epidemiology and Infection publishes original reports and reviews on all aspects of infection in humans and animals. Particular emphasis is given to the epidemiology, prevention and control of infectious diseases. The scope includes the zoonoses, tropical infections, food hygiene, vaccine studies, statistics and the clinical, social and public-health aspects of infectious disease. It has become the key international periodical in which to find the latest reports on recently discovered infections and new technology. For those concerned with policy and planning for the control of infections, the papers on mathematical modelling of epidemics caused by historical, current and emergent infections will be of particular value.